(EQT) EQT - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US26884L1098
Stock: Natural Gas, Hydrocarbons, Liquids, Pipeline
Total Rating 59
Risk 79
Buy Signal 0.56
| Risk 5d forecast | |
|---|---|
| Volatility | 33.5% |
| Relative Tail Risk | -5.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.72 |
| Alpha | 13.05 |
| Character TTM | |
|---|---|
| Beta | 0.691 |
| Beta Downside | 1.859 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.62% |
| CAGR/Max DD | 0.94 |
EPS (Earnings per Share)
Revenue
Description: EQT EQT March 05, 2026
EQT Corporation explores, produces, gathers, and transmits hydrocarbons and natural gas. The company operates in the Appalachian Basin, a significant natural gas-producing region in the United States.
EQT sells natural gas, natural gas liquids, and oil to marketers, utilities, and industrial customers. Its business model includes marketing services, pipeline capacity management, risk management, and hedging activities, common practices in the energy sector to mitigate price volatility.
Founded in 1888, EQT Corporation is headquartered in Pittsburgh, Pennsylvania. Consider exploring ValueRay for deeper insights into EQTs financial performance and market position.
Headlines to watch out for
- Natural gas prices dictate revenue and profitability
- Regulatory changes impact Appalachian Basin operations
- Acquisition strategy drives production growth
- Hedging activities mitigate commodity price volatility
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 2.04b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 5.37 > 1.0 |
| NWC/Revenue: -6.50% < 20% (prev -14.30%; Δ 7.80% < -1%) |
| CFO/TA 0.12 > 3% & CFO 5.13b > Net Income 2.04b |
| Net Debt (7.69b) to EBITDA (5.87b): 1.31 < 3 |
| Current Ratio: 0.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (624.5m) vs 12m ago 3.65% < -2% |
| Gross Margin: 48.86% > 18% (prev 0.25%; Δ 4.86k% > 0.5%) |
| Asset Turnover: 22.23% > 50% (prev 13.11%; Δ 9.12% > 0%) |
| Interest Coverage Ratio: 7.46 > 6 (EBITDA TTM 5.87b / Interest Expense TTM 438.7m) |
Altman Z'' 2.50
| A: -0.01 (Total Current Assets 1.90b - Total Current Liabilities 2.48b) / Total Assets 41.79b |
| B: 0.10 (Retained Earnings 4.24b / Total Assets 41.79b) |
| C: 0.08 (EBIT TTM 3.27b / Avg Total Assets 40.81b) |
| D: 1.65 (Book Value of Equity 23.75b / Total Liabilities 14.43b) |
| Altman-Z'' Score: 2.50 = A |
Beneish M -3.29
| DSRI: 0.70 (Receivables 1.49b/1.23b, Revenue 9.07b/5.22b) |
| GMI: 0.51 (GM 48.86% / 25.13%) |
| AQI: 0.96 (AQ_t 0.15 / AQ_t-1 0.16) |
| SGI: 1.74 (Revenue 9.07b / 5.22b) |
| TATA: -0.07 (NI 2.04b - CFO 5.13b) / TA 41.79b) |
| Beneish M-Score: -3.29 (Cap -4..+1) = AA |
What is the price of EQT shares?
As of March 18, 2026, the stock is trading at USD 64.43 with a total of 5,881,571 shares traded.
Over the past week, the price has changed by +4.21%, over one month by +11.57%, over three months by +18.86% and over the past year by +26.20%.
Over the past week, the price has changed by +4.21%, over one month by +11.57%, over three months by +18.86% and over the past year by +26.20%.
Is EQT a buy, sell or hold?
EQT has received a consensus analysts rating of 4.17.
Therefore, it is recommended to buy EQT.
- StrongBuy: 12
- Buy: 4
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the EQT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66 | 2.4% |
| Analysts Target Price | 66 | 2.4% |
EQT Fundamental Data Overview March 14, 2026
P/E Trailing = 19.4471
P/E Forward = 16.129
P/S = 4.9121
P/B = 1.6989
P/EG = 7.1643
Revenue TTM = 9.07b USD
EBIT TTM = 3.27b USD
EBITDA TTM = 5.87b USD
Long Term Debt = 7.29b USD (from longTermDebt, last quarter)
Short Term Debt = 507.1m USD (from shortTermDebt, last quarter)
Debt = 7.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.69b USD (from netDebt column, last quarter)
Enterprise Value = 47.87b USD (40.18b + Debt 7.80b - CCE 110.8m)
Interest Coverage Ratio = 7.46 (Ebit TTM 3.27b / Interest Expense TTM 438.7m)
EV/FCF = 16.82x (Enterprise Value 47.87b / FCF TTM 2.85b)
FCF Yield = 5.95% (FCF TTM 2.85b / Enterprise Value 47.87b)
FCF Margin = 31.37% (FCF TTM 2.85b / Revenue TTM 9.07b)
Net Margin = 22.48% (Net Income TTM 2.04b / Revenue TTM 9.07b)
Gross Margin = 48.86% ((Revenue TTM 9.07b - Cost of Revenue TTM 4.64b) / Revenue TTM)
Gross Margin QoQ = 45.89% (prev 36.15%)
Tobins Q-Ratio = 1.15 (Enterprise Value 47.87b / Total Assets 41.79b)
Interest Expense / Debt = 1.35% (Interest Expense 105.5m / Debt 7.80b)
Taxrate = 21.82% (208.3m / 954.7m)
NOPAT = 2.56b (EBIT 3.27b * (1 - 21.82%))
Current Ratio = 0.76 (Total Current Assets 1.90b / Total Current Liabilities 2.48b)
Debt / Equity = 0.33 (Debt 7.80b / totalStockholderEquity, last quarter 23.75b)
Debt / EBITDA = 1.31 (Net Debt 7.69b / EBITDA 5.87b)
Debt / FCF = 2.70 (Net Debt 7.69b / FCF TTM 2.85b)
Total Stockholder Equity = 22.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.00% (Net Income 2.04b / Total Assets 41.79b)
RoE = 9.16% (Net Income TTM 2.04b / Total Stockholder Equity 22.26b)
RoCE = 11.07% (EBIT 3.27b / Capital Employed (Equity 22.26b + L.T.Debt 7.29b))
RoIC = 8.42% (NOPAT 2.56b / Invested Capital 30.37b)
WACC = 7.26% (E(40.18b)/V(47.98b) * Re(8.46%) + D(7.80b)/V(47.98b) * Rd(1.35%) * (1-Tc(0.22)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.41%
[DCF] Terminal Value 83.72% ; FCFF base≈1.94b ; Y1≈2.39b ; Y5≈4.07b
[DCF] Fair Price = 117.2 (EV 80.88b - Net Debt 7.69b = Equity 73.19b / Shares 624.3m; r=7.26% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -10.82 | EPS CAGR: 2.85% | SUE: 1.94 | # QB: 2
Revenue Correlation: -18.08 | Revenue CAGR: -2.36% | SUE: 1.26 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.70 | Chg7d=-0.012 | Chg30d=-0.025 | Revisions Net=-1 | Analysts=19
EPS current Year (2026-12-31): EPS=4.64 | Chg7d=-0.030 | Chg30d=+0.513 | Revisions Net=+5 | Growth EPS=+52.3% | Growth Revenue=+14.4%
EPS next Year (2027-12-31): EPS=4.63 | Chg7d=-0.013 | Chg30d=-0.119 | Revisions Net=-2 | Growth EPS=-0.2% | Growth Revenue=-1.6%
[Analyst] Revisions Ratio: -0.07 (7 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 8.5% - Earnings Yield 5.1%)
[Growth] Growth Spread = -20.5% (Analyst -17.2% - Implied 3.3%)
P/E Forward = 16.129
P/S = 4.9121
P/B = 1.6989
P/EG = 7.1643
Revenue TTM = 9.07b USD
EBIT TTM = 3.27b USD
EBITDA TTM = 5.87b USD
Long Term Debt = 7.29b USD (from longTermDebt, last quarter)
Short Term Debt = 507.1m USD (from shortTermDebt, last quarter)
Debt = 7.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.69b USD (from netDebt column, last quarter)
Enterprise Value = 47.87b USD (40.18b + Debt 7.80b - CCE 110.8m)
Interest Coverage Ratio = 7.46 (Ebit TTM 3.27b / Interest Expense TTM 438.7m)
EV/FCF = 16.82x (Enterprise Value 47.87b / FCF TTM 2.85b)
FCF Yield = 5.95% (FCF TTM 2.85b / Enterprise Value 47.87b)
FCF Margin = 31.37% (FCF TTM 2.85b / Revenue TTM 9.07b)
Net Margin = 22.48% (Net Income TTM 2.04b / Revenue TTM 9.07b)
Gross Margin = 48.86% ((Revenue TTM 9.07b - Cost of Revenue TTM 4.64b) / Revenue TTM)
Gross Margin QoQ = 45.89% (prev 36.15%)
Tobins Q-Ratio = 1.15 (Enterprise Value 47.87b / Total Assets 41.79b)
Interest Expense / Debt = 1.35% (Interest Expense 105.5m / Debt 7.80b)
Taxrate = 21.82% (208.3m / 954.7m)
NOPAT = 2.56b (EBIT 3.27b * (1 - 21.82%))
Current Ratio = 0.76 (Total Current Assets 1.90b / Total Current Liabilities 2.48b)
Debt / Equity = 0.33 (Debt 7.80b / totalStockholderEquity, last quarter 23.75b)
Debt / EBITDA = 1.31 (Net Debt 7.69b / EBITDA 5.87b)
Debt / FCF = 2.70 (Net Debt 7.69b / FCF TTM 2.85b)
Total Stockholder Equity = 22.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.00% (Net Income 2.04b / Total Assets 41.79b)
RoE = 9.16% (Net Income TTM 2.04b / Total Stockholder Equity 22.26b)
RoCE = 11.07% (EBIT 3.27b / Capital Employed (Equity 22.26b + L.T.Debt 7.29b))
RoIC = 8.42% (NOPAT 2.56b / Invested Capital 30.37b)
WACC = 7.26% (E(40.18b)/V(47.98b) * Re(8.46%) + D(7.80b)/V(47.98b) * Rd(1.35%) * (1-Tc(0.22)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.41%
[DCF] Terminal Value 83.72% ; FCFF base≈1.94b ; Y1≈2.39b ; Y5≈4.07b
[DCF] Fair Price = 117.2 (EV 80.88b - Net Debt 7.69b = Equity 73.19b / Shares 624.3m; r=7.26% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -10.82 | EPS CAGR: 2.85% | SUE: 1.94 | # QB: 2
Revenue Correlation: -18.08 | Revenue CAGR: -2.36% | SUE: 1.26 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.70 | Chg7d=-0.012 | Chg30d=-0.025 | Revisions Net=-1 | Analysts=19
EPS current Year (2026-12-31): EPS=4.64 | Chg7d=-0.030 | Chg30d=+0.513 | Revisions Net=+5 | Growth EPS=+52.3% | Growth Revenue=+14.4%
EPS next Year (2027-12-31): EPS=4.63 | Chg7d=-0.013 | Chg30d=-0.119 | Revisions Net=-2 | Growth EPS=-0.2% | Growth Revenue=-1.6%
[Analyst] Revisions Ratio: -0.07 (7 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 8.5% - Earnings Yield 5.1%)
[Growth] Growth Spread = -20.5% (Analyst -17.2% - Implied 3.3%)